Back
Lexaria Bioscience Vs. ESSA Pharma Industry Stock Comparison
Sell
18
LEXX
Lexaria Bioscience
Last Price:
2.27
Seasonality Move:
75.5%
Sell
21
EPIX
ESSA Pharma
Last Price:
1.63
Seasonality Move:
25.98%
Sell
18
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
- The current Lexaria Bioscience [LEXX] share price is $2.28. The Score for LEXX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- LEXX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
21
ESSA Pharma (EPIX)
is a Sell
Is ESSA Pharma a Buy, Sell or Hold?
- The current ESSA Pharma [EPIX] share price is $1.63. The Score for EPIX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- EPIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $2.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing selling pressure, which indicates risk of future bearish movement.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $1.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing slight buying pressure.
LEXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 29.97 | Sell |
Chaikin Money Flow: | -63789 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.47 - 3.15) | Sell |
Bollinger Bands (100): | (2.68 - 3.42) | Sell |
EPIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 20.38 | Sell |
Chaikin Money Flow: | 1180694 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.28 - 6.7) | Sell |
Bollinger Bands (100): | (4.6 - 6.26) | Sell |
LEXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.41 | Sell |
20-day SMA: | 2.72 | Sell |
50-day SMA: | 3.04 | Sell |
200-day SMA: | 2.99 | Sell |
8-day EMA: | 2.4 | Sell |
20-day EMA: | 2.64 | Sell |
50-day EMA: | 2.9 | Sell |
200-day EMA: | 2.82 | Sell |
EPIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.49 | Sell |
20-day SMA: | 5.35 | Sell |
50-day SMA: | 5.79 | Sell |
200-day SMA: | 6.62 | Sell |
8-day EMA: | 3.93 | Sell |
20-day EMA: | 4.97 | Sell |
50-day EMA: | 5.48 | Sell |
200-day EMA: | 5.81 | Sell |
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
ESSA Pharma Earnings Growth & EPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.22 per share.
Lexaria Bioscience Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ESSA Pharma Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |